GlassScriptPhysician profile
Abhinav Agrawal
NPI 1487094082
$54,612.03
in general payments reported to CMS, 2019-2025
14 companies · $5,261 in 2025
The $5,261 reported for 2025 was more than what 88% of Pulmonary Disease providers received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $28K · 2020: $16K · 2021: $178 · 2022: $705 · 2023: $4,839 · 2024: $15.84 · 2025: $5,261.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $4,422 · Food and Beverage: $3,194 · Education: $2,500.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $4,422.03 |
| Food and Beverage | $3,193.98 |
| Education | $2,500.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $32,503.14 | 2019-2022 | |
| Cook Medical LLC | $10,000.00 | 2019 | |
| Noah Medical Corporation | $4,808.68 | 2023-2025 | Galaxy |
| Intuitive Surgical, INC. | $4,307.07 | 2021-2025 | Da Vinci Surgical System |
| Ethicon INC. | $1,138.94 | 2019-2023 | Monarch Platform |
| Pinnacle Biologics, INC | $921.44 | 2019 | |
| Pulmonx Corporation | $314.29 | 2023-2025 | Pulmonx Chartis Tablet Console, Chartis Catheter, Zephyr Endobronchial Valve |
| Covidien LP | $219.00 | 2019-2020 | |
| United Therapeutics Corporation | $146.23 | 2023 | |
| Astrazeneca Pharmaceuticals LP | $119.57 | 2019 | |
| Galvanize Therapeutics, INC | $73.50 | 2025 | Aliya System |
| Olympus Corporation of The Americas | $43.86 | 2022 | |
| Olympus America INC. | $16.31 | 2025 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$50,000.00 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Abhinav Agrawal listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.